Health Care Sector
831 health care stocks ranked by market capitalization, page 2 of 17. Updated November 22, 2026.
Today
-0.41%Health Care stocks ranked 51–100
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 51 | CNC | Centene Corporation | 63.78 | -2.74% | 7.01M | $31.58B |
| 52 | GMAB | Genmab A/S ADS | 50.60 | -1.46% | 2.90M | $31.20B |
| 53 | INSM | Insmed Incorporated | 141.33 | -2.17% | 6.22M | $31.01B |
| 54 | LH | Labcorp Holdings Inc. | 367.13 | -0.47% | 890.42K | $29.81B |
| 55 | DXCM | DexCom Inc. | 79.32 | -1.08% | 4.61M | $29.58B |
| 56 | ILMN | Illumina Inc. | 192.82 | -3.90% | 1.95M | $29.15B |
| 57 | DGX | Quest Diagnostics Incorporated | 258.28 | -0.31% | 1.37M | $28.42B |
| 58 | ROIV | Roivant Sciences Ltd. | 38.66 | -0.78% | 3.97M | $28.01B |
| 59 | PHG | Koninklijke Philips N.V. NY Registry Shares | 28.61 | -2.19% | 2.42M | $27.97B |
| 60 | WST | West Pharmaceutical Services Inc. | 390.30 | -1.61% | 623.34K | $27.19B |
| 61 | STE | STERIS plc (Ireland) | 255.76 | +0.39% | 823.42K | $24.84B |
| 62 | UTHR | United Therapeutics Corporation | 554.73 | -0.78% | 367.68K | $23.63B |
| 63 | INCY | Incyte Corp. | 114.63 | -1.07% | 1.54M | $23.36B |
| 64 | VTRS | Viatris Inc. | 19.63 | -1.26% | 9.27M | $22.50B |
| 65 | THC | Tenet Healthcare Corporation | 263.19 | -0.15% | 705.00K | $20.95B |
| 66 | BNTX | BioNTech SE ADR | 80.96 | -0.52% | 1.71M | $20.07B |
| 67 | GH | Guardant Health Inc. | 145.83 | +0.16% | 2.76M | $19.73B |
| 68 | ALNY | Alnylam Pharmaceuticals Inc. | 143.82 | -2.71% | 2.33M | $19.26B |
| 69 | ZBH | Zimmer Biomet Holdings Inc. | 101.10 | -0.36% | 2.96M | $19.13B |
| 70 | MEDP | Medpace Holdings Inc. | 610.54 | -3.70% | 236.69K | $17.08B |
| 71 | ASND | Ascendis Pharma A/S | 252.73 | -1.26% | 602.89K | $16.58B |
| 72 | EXEL | Exelixis Inc. | 64.63 | -1.82% | 2.19M | $15.77B |
| 73 | NBIX | Neurocrine Biosciences Inc. | 150.57 | -3.84% | 1.59M | $15.24B |
| 74 | CRL | Charles River Laboratories International Inc. | 314.32 | -4.15% | 1.15M | $15.06B |
| 75 | BBIO | BridgeBio Pharma Inc. | 76.03 | -2.75% | 1.48M | $14.81B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 230.26 | -2.62% | 984.64K | $14.78B |
| 77 | ULS | UL Solutions Inc. Class A | 72.64 | -2.99% | 680.47K | $14.67B |
| 78 | SOLV | Solventum Corporation | 84.50 | -1.52% | 658.35K | $14.36B |
| 79 | GKOS | Glaukos Corporation | 237.31 | -0.33% | 1.09M | $14.05B |
| 80 | ICLR | ICON plc | 186.71 | -1.92% | 735.39K | $13.99B |
| 81 | BAX | Baxter International Inc. | 25.39 | 0.00% | 4.32M | $13.14B |
| 82 | EHC | Encompass Health Corporation | 133.65 | +1.04% | 911.93K | $13.11B |
| 83 | ELAN | Elanco Animal Health Incorporated | 25.74 | -2.09% | 5.83M | $12.87B |
| 84 | PEN | Penumbra Inc. | 319.12 | -0.28% | 205.41K | $12.58B |
| 85 | BTSG | BrightSpring Health Services Inc. | 62.89 | -1.77% | 3.31M | $12.51B |
| 86 | SNN | Smith & Nephew SNATS Inc. | 29.83 | 0.00% | 1.23M | $12.47B |
| 87 | RDY | Dr. Reddy's Laboratories Ltd | 14.89 | +0.40% | 1.74M | $12.41B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 60.41 | -1.64% | 6.06M | $11.70B |
| 89 | TECH | Bio-Techne Corp | 72.67 | -0.04% | 3.66M | $11.42B |
| 90 | COO | The Cooper Companies Inc. | 58.88 | -2.40% | 2.08M | $11.20B |
| 91 | ALGN | Align Technology Inc. | 155.17 | -2.82% | 1.31M | $10.94B |
| 92 | FMS | Fresenius Medical Care AG ADR | 20.44 | +1.54% | 1.34M | $10.61B |
| 93 | RGEN | Repligen Corporation | 163.81 | -3.81% | 697.68K | $10.47B |
| 94 | HALO | Halozyme Therapeutics Inc. | 91.35 | -1.82% | 1.50M | $10.41B |
| 95 | MOH | Molina Healthcare Inc | 198.39 | -2.43% | 800.42K | $10.36B |
| 96 | UHS | Universal Health Services Inc. | 179.43 | +2.54% | 908.72K | $10.34B |
| 97 | ENSG | The Ensign Group Inc. | 176.32 | -0.15% | 252.65K | $10.29B |
| 98 | QGEN | Qiagen N.V. | 49.30 | -0.66% | 2.63M | $10.18B |
| 99 | DVA | DaVita Inc. | 161.03 | +3.00% | 730.12K | $10.13B |
| 100 | KYMR | Kymera Therapeutics Inc. | 115.31 | -3.42% | 1.28M | $9.84B |
Prices as of Nov 22, 9:20 AM EST. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer